OptimizeRx Corp

corporate_fare Company Profile

OptimizeRx Corp

Exchange: NASDAQSector: Trade & Services

show_chartPrice Chart

Loading chart...

feed OPRX - Latest Insights

Filing Type

Date Range

OPRX

Apr 08, 2026, 5:46 PM EDT

Filing Type: 8-K

Importance Score:

8

OptimizeRx Appoints Microsoft Health & Life Sciences COO Mary Varghese Presti to Board, Expanding Strategic Expertise

Sentiment: Positive

View Wiseek Article

OPRX

Mar 12, 2026, 4:03 PM EDT

Filing Type: 10-K

Importance Score:

8

OptimizeRx Confirms Strong 2025 Profitability, Debt Extension, $10M Buyback, and Discloses Material Weakness

Sentiment: Positive

View Wiseek Article

OPRX

Mar 05, 2026, 5:04 PM EST

Source: GlobeNewswire

Importance Score:

9

OptimizeRx Reports Record Q4 Profit, 19% FY Revenue Growth, and $10M Share Buyback

Sentiment: Positive

View Wiseek Article

OPRX

Mar 05, 2026, 4:09 PM EST

Filing Type: 8-K

Importance Score:

8

OptimizeRx Reports Strong 2025 Results, Authorizes $10M Share Repurchase, and Extends Debt Maturity

Sentiment: Positive

View Wiseek Article